ASTRAZENBSEAstraZeneca Pharma India LtdMinimalNeutral
Announced Wed, 20 May · 20:27 IST

Please find the enclosed intimation of the Company as per the captioned subject for your reference.

ASTRAZEN · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
-0.2%1-day move
₹8592.00
prior close
₹8708.00
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-1.3-1.0-1.0-0.9-0.2+1.9+5.0+0.2-1.3+0.8-4.2-0.2-6.1
Up moveDown movePending
AI summary

AstraZeneca Pharma India has informed stock exchanges about the Key Managerial Personnel (KMPs) authorized to determine materiality of events under SEBI regulations. Three senior officials are authorized: Mr. Praveen Rao Akkinepally (Managing Director), Ms. Bhavana Agrawal (CFO & Director), and Ms. Tanya Sanish (Company Secretary & Compliance Officer). All three can act jointly and/or severally. Their contact email and phone number (080 6774 8000) have been shared for regulatory communication purposes.

Likely market impact

This is a routine compliance filing with no direct impact on company financials or operations. It simply updates the authorized personnel list for material event disclosures, which is standard regulatory practice.